This week’s InnovationRx covers highlights from the J.P. Morgan Healthcare Conference, attended by 8,000 industry professionals amidst heightened security. Key announcements include Johnson & Johnson’s $14.6 billion acquisition of Intra-Cellular Therapies and Eli Lilly’s $2.5 billion purchase of Scorpion Therapeutics. The conference also noted a potential surge in drug mergers due to an upcoming patent cliff. Additionally, Moderna is leading the development of a norovirus vaccine, while California’s wildfires pose serious public health challenges. Nvidia announced AI collaborations to enhance healthcare solutions, reflecting the ongoing advancements in digital health and medtech sectors.